An Antisense Oligonucleotide for Hereditary Angioedema

N Engl J Med. 2022 Mar 17;386(11):1083-1085. doi: 10.1056/NEJMe2201729.

Authors

Hilary J Longhurst¹, Rohan Ameratunga¹

Affiliation

¹ From the Department of Immunology, Auckland City Hospital (H.J.L., R.A.), and the Departments of Medicine (H.J.L.) and Molecular Medicine and Pathology (R.A.), University of Auckland - both in Auckland, New Zealand.

PMID: 35294818
DOI: 10.1056/NEJMe2201729

No abstract available

Publication types

Editorial
Comment

MeSH terms

Angioedemas, Hereditary* / genetics
Complement C1 Inhibitor Protein
Humans
Oligonucleotides / therapeutic use
Oligonucleotides, Antisense / therapeutic use

Substances

Complement C1 Inhibitor Protein
Oligonucleotides
Oligonucleotides, Antisense